Volume 4 Number 2
Editorial
28
Transcatheter Aortic Valve Implantation – TAVI: so much done... yet so far to goEuroInterv.2008;4:169-172
29
Transcatheter aortic valve implantation – should we do it just because we can?EuroInterv.2008;4:173-175
30
“I did not see it coming”... the hard way for the prevention of complicationsEuroInterv.2008;4:176-177
EAPCI column
Focus article
32
Management of two major complications in the cardiac catheterisation laboratory:
the no-reflow phenomenon and coronary perforationsEuroInterv.2008;4:181-192
33
Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventionsEuroInterv.2008;4:181-192
34
Radiation safety during percutaneous coronary procedures: how to reduce radiation exposure and its complicationsEuroInterv.2008;4:181-192
35
Constructing a checklist for the prevention of complications during percutaneous coronary interventionEuroInterv.2008;4:181-192
36
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, Cribier A, de Jaegere P, Fournial G, Kappetein AP, Kovac J, Ludgate S, Maisano F, Moat N, Mohr F, Nataf P, Pierard L, Pomar J-L, Schofer J, Tornos P, Tuzcu M, van Hout B, von Segesser L, Walther T
EuroInterv.2008;4:193-199
Clinical research
37
One year results of a new in situ length-adjustable stent platform with a biodegradable Biolimus A9 eluting polymer: results of the CUSTOM-II trial Stella P, Mueller R, Pavlakis G, de Bruyne B, Hauptmann K, Morice M-C, Chevalier B, Fajadet J, Sievert H, Grube E, for the Custom-II investigators
EuroInterv.2008;4:200-207
38
Improved renal function and blood pressure control following renal artery angioplasty: The Renal Artery Angioplasty in Patients with Renal Insufficiency and Hypertension Using a Dedicated Renal Stent Device Study (PRECISION)Rastan A, Krankenberg H, Müller-Hülsbeck S, Sixt S, Tübler T, Müller C, Schwarzwälder U, Frank U, Schwarz T, Leppaenen O, Neumann F-J, Zeller T
EuroInterv.2008;4:208-213
39
Antiplatelet response to the 150-mg maintenance dose of clopidogrel in patients with insufficient platelet inhibition after clopidogrel loading for elective coronary stent placementEuroInterv.2008;4:214-221
40
Systematic primary aspiration in acute myocardial percutaneous intervention: a multicentre randomised controlled trial of the export aspiration catheterChevalier B, Gilard M, Lang I, Commeau P, Roosen J, Hanssen M, Lefèvre T, Carrié D, Bartorelli A, Montalescot G, Parikh K
EuroInterv.2008;4:222-228
41
Safety in simple versus complex stenting of coronary artery bifurcation lesions. The Nordic Bifurcation Study 14-month follow-up resultsJensen J, Galløe A, Lassen J, Erglis A, Kumsars I, Steigen T, Wiseth R, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemelä M, Kervinen K, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A, Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Thuesen L, for the Nordic-Baltic PCI Study Group
EuroInterv.2008;4:229-233
42
Titanium-nitride-oxide coated stents versus paclitaxel-eluting stents in acute myocardial infarction: a 12-months follow-up report from the TITAX AMI trialKarjalainen P, Ylitalo A, Niemelä M, Kervinen K, Mäkikallio T, Pietilä M, Sia J, Tuomainen P, Nyman K, Juhani Airaksinen KE
EuroInterv.2008;4:234-241
43
Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) CoreValve ReValving System: results from the multicentre, expanded evaluation registry 1-year following CE mark approvalPiazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde J-C, de Jaegere P, Serruys PW, on behalf of the clinical centres who actively participated in the registry
EuroInterv.2008;4:242-249
44
Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacementOtten A, van Domburg R, van Gameren M, Kappetein AP, Takkenberg J, Bogers A, Serruys PW, de Jaegere P
EuroInterv.2008;4:250-255
46
Elective implantation of sirolimus-eluting stents for bifurcated and non-bifurcated unprotected left main coronary artery lesions: clinical outcomes at one yearBarragan P, Fajadet J, Sheiban I, Serruys PW, Colombo A, Seabra-Gomes R, Goy J-J, Cook S, Rubino P, Lefèvre T
EuroInterv.2008;4:262-270
47
Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registrySuessenbacher A, Doerler J, Alber H, Aichinger J, Altenberger J, Benzer W, Christ G, Globits S, Huber K, Karnik R, Norman G, Siostrzonek P, Zenker G, Pachinger O, Weidinger F
EuroInterv.2008;4:271-276
48
Use of the Venture™ wire control catheter to access complex coronary lesions: how to turn procedural failure into successAranzulla T, Sangiorgi G, Bartorelli A, Cosgrave J, Corbett S, Fabbiocchi F, Montorsi P, Montorfano M, Trabattoni D, Colombo A
EuroInterv.2008;4:277-284
49
Quantitative multi-modality imaging analysis of a bioabsorbable poly-L-lactic acid stent design in the acute phase: a comparison between 2- and 3D-QCA, QCU and QMSCT-CABruining N, Tanimoto S, Otsuka M, Weustink A, Ligthart J, de Winter S, van Mieghem C, Nieman K, de Feyter P, van Domburg R, Serruys PW
EuroInterv.2008;4:285-291
How should I treat?
50
How should I treat a patient with severe and symptomatic aortic stenosis who is rejected for surgical and transfemoral valve replacement and in whom a transapical implantation was aborted? de Jaegere P, van Dijk L, van Sambeek M, Kappetein AP, Ramos F, Maugenest A, de Ronde-Tilmans M, Serruys PW
EuroInterv.2008;4:292-296
Image in cardiology
51
False lumen stenting: uncommon stent occlusion demonstrated by intravascular ultrasound EuroInterv.2008;4:297
Volume 4 Number 2 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Cordis, a Johnson & Johnson company
- GE Healthcare
- Hexacath
- Invatec
- Medtronic
- Terumo



